Neuphoria Therapeutics Inc. (NEUP) › Cash & EquivalentsNeuphoria Therapeutics Inc. (NEUP) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $12.10M2024: $12.61M2025: $14.21M$14.21M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$14.21M+12.7%2024$12.61M+4.2%2023$12.10M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share